CytoDyn Balance Sheet

Financials in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 28, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021
Cash & Equivalents	15.66	11.9	3.11	2.54	4.23	33.94
Cash & Short-Term Investments	15.66	11.9	3.11	2.54	4.23	33.94
Cash Growth	-4.54%	282.73%	22.39%	-39.94%	-87.53%	137.66%
Other Receivables	-	2	-	-	-	-
Receivables	-	2	-	-	-	-
Prepaid Expenses	0.45	0.25	0.46	1.17	5.2	0.62
Restricted Cash	-	-	6.7	6.51	-	-
Other Current Assets	2.34	3.72	0.54	0.59	1.09	1.54
Total Current Assets	18.44	17.88	10.82	10.81	10.52	36.1
Property, Plant & Equipment	0.03	0.13	0.26	0.4	0.54	0.85
Other Intangible Assets	-	-	-	-	-	1.65
Other Long-Term Assets	0.03	0.04	0.06	0.09	18.13	93.48
Total Assets	18.5	18.05	11.14	11.29	29.19	132.08
Accounts Payable	13.48	14.69	29.56	62.73	67.97	65.9
Accrued Expenses	14.8	20.22	17.6	17.13	14.84	21.08
Current Portion of Long-Term Debt	-	27.2	29.79	34.42	36.24	62.75
Current Portion of Leases	0.03	0.14	0.14	0.14	0.13	0.18
Other Current Liabilities	22.12	8.27	7.09	5.39	3.98	2.65
Total Current Liabilities	50.43	70.52	84.18	119.8	123.16	152.55
Long-Term Debt	28.79	-	-	0.71	-	-
Long-Term Leases	-	-	0.14	0.28	0.42	0.55
Other Long-Term Liabilities	43.57	43.57	43.57	-	-	-
Total Liabilities	122.78	114.09	127.89	120.79	123.58	153.1
Common Stock	1.36	1.25	1.06	0.92	0.72	0.63
Additional Paid-In Capital	814.98	790.5	773.71	731.27	671.01	532.03
Retained Earnings	-920.62	-887.79	-891.53	-841.69	-766.13	-553.68
Total Common Equity	-104.29	-96.04	-116.76	-109.5	-94.4	-21.02
Shareholders' Equity	-104.29	-96.04	-116.76	-109.5	-94.4	-21.02
Total Liabilities & Equity	18.5	18.05	11.14	11.29	29.19	132.08
Total Debt	28.82	27.34	30.08	35.55	36.8	63.47
Net Cash (Debt)	-13.16	-15.44	-26.97	-33.01	-32.57	-29.53
Net Cash Per Share	-0.01	-0.01	-0.03	-0.04	-0.05	-0.05
Filing Date Shares Outstanding	1,366	1,251	1,214	930.52	810.28	632.14
Total Common Shares Outstanding	1,358	1,249	1,059	918.61	719.59	625.68
Working Capital	-31.99	-52.64	-73.37	-108.99	-112.65	-116.44
Book Value Per Share	-0.08	-0.08	-0.11	-0.12	-0.13	-0.03
Tangible Book Value	-104.29	-96.04	-116.76	-109.5	-94.4	-22.67
Tangible Book Value Per Share	-0.08	-0.08	-0.11	-0.12	-0.13	-0.04

Updated Feb 28, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.